SYSTEMATIC REVIEW article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1612417

The global leadership initiative on malnutrition criteria for the diagnosis of malnutrition in patients with chronic liver diseases: A systematic review and meta-analysis

Provisionally accepted
Zhiming  WangZhiming Wang1Yuping  CaoYuping Cao2Yumei  HeYumei He3Menghao  HaoMenghao Hao4Shiyan  WuShiyan Wu2Lu  LiLu Li2Qiong  WangQiong Wang1Xiaobin  SunXiaobin Sun1,4Liping  WuLiping Wu1,4*
  • 1Chengdu Third People's Hospital, Chengdu, China
  • 2Southwest Medical University, Luzhou, Sichuan, China
  • 3North Sichuan Medical College, Nanchong, Sichuan Province, China
  • 4Southwest Jiaotong University, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

Background: Malnutrition in patients with chronic liver disease (CLD) is linked to increased mortality and a high risk of morbidity. Assessing the nutritional status of patients with CLD is challenging. The Global Leadership Initiative for Malnutrition (GLIM) offers a novel diagnostic framework for malnutrition. However, the efficacy of GLIM in CLD patients has not been validated. Methods: A systematic review and meta-analysis were conducted to evaluate the utility and diagnostic accuracy of the GLIM criteria in adult patients with CLD, involving a search of seven databases for relevant studies. The evaluation of quality was conducted with the QUADAS-2 tool. Results: The analysis included a total of five studies. The sample size ranged from 109 to 406 among different studies. According to the GLIM criteria, around 21.2% to 69.9% of individuals were identified as having malnutrition. Simultaneously, the subjective global assessment (SGA) detected malnourished patients ranging from 35.0% to 86.0%. Five studies compared the GLIM with the SGA. The nutritional assessment process in the studies was not clear according to the QUADAS-2 tool. The overall specificity of the meta-analysis was 85.8% (95% CI: 82.5%-88.7%) and the overall sensitivity was 49.1% (95% CI: 45.5%-52.8%). Conclusion: This is the first systematic review and meta-analysis on GLIM criteria, SGA and CLD patients. The applicability and reliability of the GLIM criteria in CLD patients remain constrained. Furthermore, certain validation studies that are parallel and predictive may have methodological limitations. Additional research is needed to confirm the applicability of the GLIM criteria in patients with CLD.

Keywords: GLIM, SGA, chronic liver disease, Meta-analysis, Systematic review

Received: 15 Apr 2025; Accepted: 02 Jun 2025.

Copyright: © 2025 Wang, Cao, He, Hao, Wu, Li, Wang, Sun and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Liping Wu, Chengdu Third People's Hospital, Chengdu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.